Jamie Jacobs, PhD, presented “PROWESS: (PROstate Cancer Wearables, Exercise, and Structured Supports)” at the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 8, 2024.
How to cite: Jacobs, Jamie. “PROWESS: (PROstate Cancer Wearables, Exercise, and Structured Supports)” October 2024. Accessed Jan 2026. https://grandroundsinurology.com/prowess-prostate-cancer-wearables-exercise-and-structured-supports/
PROWESS: (PROstate Cancer Wearables, Exercise, and Structured Supports) – Summary#
Jamie Jacobs, PhD, a clinical psychologist at Mass General Cancer Center, presents a 12-minute talk on the PROWESS study, a culturally responsive intervention for Black and Latino men with metastatic prostate cancer undergoing androgen deprivation therapy (ADT). The study addresses disparities in health behaviors, particularly physical activity, which significantly impacts these populations’ quality of life and management of ADT side effects.
PROWESS is a six-session Zoom-based program emphasizing physical activity, symptom management, and quality of life enhancement. The intervention incorporates tools like Fitbits, cognitive behavioral therapy, relaxation techniques, and community support, ensuring accessibility and cultural sensitivity. Participants also engage in semi-structured interviews to provide feedback, which informs iterative refinements to the program.
Dr. Jacobs emphasizes PROWESS’s potential to transform ADT management and close disparities in prostate cancer care.
The Global Summit on Precision Diagnosis and Treatment of Prostate Cancer is a unique multi-disciplinary forum organized to inform the key health care stakeholders about the emerging advances in clinical case and research and create a consensus-based vision for the future of precision care and educational and research strategy for its realization. The mission of the Summit is to fill the currently existing gap between the key experts of in vivo imaging, the world authorities in the in vitro fluid- and tissue-based molecular diagnostics, including genomics, and thought leaders in the development of novel observation strategies (e.g., active surveillance, or AS) and therapeutic interventions.
